214 related articles for article (PubMed ID: 35098994)
1. CONVINCE in the context of existing evidence on haemodiafiltration.
Vernooij RWM; Bots ML; Strippoli GFM; Canaud B; Cromm K; Woodward M; Blankestijn PJ;
Nephrol Dial Transplant; 2022 May; 37(6):1006-1013. PubMed ID: 35098994
[TBL] [Abstract][Full Text] [Related]
2. Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.
Blankestijn PJ; Fischer KI; Barth C; Cromm K; Canaud B; Davenport A; Grobbee DE; Hegbrant J; Roes KC; Rose M; Strippoli GF; Vernooij RW; Woodward M; de Wit GA; Bots ML
BMJ Open; 2020 Feb; 10(2):e033228. PubMed ID: 32029487
[TBL] [Abstract][Full Text] [Related]
3. The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes.
Caskey FJ; Procter S; MacNeill SJ; Wade J; Taylor J; Rooshenas L; Liu Y; Annaw A; Alloway K; Davenport A; Power A; Farrington K; Mitra S; Wheeler DC; Law K; Lewis-White H; Ben-Shlomo Y; Hollingworth W; Donovan J; Lane JA
Trials; 2022 Jun; 23(1):532. PubMed ID: 35761367
[TBL] [Abstract][Full Text] [Related]
4. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials.
Peters SA; Bots ML; Canaud B; Davenport A; Grooteman MP; Kircelli F; Locatelli F; Maduell F; Morena M; Nubé MJ; Ok E; Torres F; Woodward M; Blankestijn PJ;
Nephrol Dial Transplant; 2016 Jun; 31(6):978-84. PubMed ID: 26492924
[TBL] [Abstract][Full Text] [Related]
5. Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study.
Shroff R; Bayazit A; Stefanidis CJ; Askiti V; Azukaitis K; Canpolat N; Agbas A; Anarat A; Aoun B; Bakkaloglu S; Bhowruth D; Borzych-Dużałka D; Bulut IK; Büscher R; Dempster C; Duzova A; Habbig S; Hayes W; Hegde S; Krid S; Licht C; Litwin M; Mayes M; Mir S; Nemec R; Obrycki L; Paglialonga F; Picca S; Ranchin B; Samaille C; Shenoy M; Sinha M; Smith C; Spasojevic B; Vidal E; Vondrák K; Yilmaz A; Zaloszyc A; Fischbach M; Schaefer F; Schmitt CP
BMC Nephrol; 2018 Aug; 19(1):199. PubMed ID: 30097064
[TBL] [Abstract][Full Text] [Related]
6. Clinical evidence on haemodiafiltration.
Blankestijn PJ; Grooteman MP; Nube MJ; Bots ML
Nephrol Dial Transplant; 2018 Oct; 33(suppl_3):iii53-iii58. PubMed ID: 30281128
[TBL] [Abstract][Full Text] [Related]
7. High-efficiency on-line haemodiafiltration improves conduit artery endothelial function compared with high-flux haemodialysis in end-stage renal disease patients.
Bellien J; Fréguin-Bouilland C; Joannidès R; Hanoy M; Rémy-Jouet I; Monteil C; Iacob M; Martin L; Renet S; Vendeville C; Godin M; Thuillez C; Le Roy F
Nephrol Dial Transplant; 2014 Feb; 29(2):414-22. PubMed ID: 24235073
[TBL] [Abstract][Full Text] [Related]
8. Haemodiafiltration does not lower protein-bound uraemic toxin levels compared with haemodialysis in a paediatric population.
Snauwaert E; Van Biesen W; Raes A; Glorieux G; Vande Walle J; Roels S; Vanholder R; Askiti V; Azukaitis K; Bayazit A; Canpolat N; Fischbach M; Saoussen K; Litwin M; Obrycki L; Paglialonga F; Ranchin B; Samaille C; Schaefer F; Schmitt CP; Spasojevic B; Stefanidis CJ; Shroff R; Eloot S
Nephrol Dial Transplant; 2020 Apr; 35(4):648-656. PubMed ID: 31361315
[TBL] [Abstract][Full Text] [Related]
9. The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trials.
Vernooij RWM; Law W; Peters SAE; Canaud B; Davenport A; Grooteman MPC; Kircelli F; Locatelli F; Maduell F; Morena M; Nubé MJ; Ok E; Torres F; Woodward M; Blankestijn PJ; Bots ML;
BMC Nephrol; 2021 Feb; 22(1):70. PubMed ID: 33632160
[TBL] [Abstract][Full Text] [Related]
10. The effect of high-volume online haemodiafiltration on nutritional status and body composition: the ProtEin Stores prEservaTion (PESET) study.
Molina P; Vizcaíno B; Molina MD; Beltrán S; González-Moya M; Mora A; Castro-Alonso C; Kanter J; Ávila AI; Górriz JL; Estañ N; Pallardó LM; Fouque D; Carrero JJ
Nephrol Dial Transplant; 2018 Jul; 33(7):1223-1235. PubMed ID: 29370428
[TBL] [Abstract][Full Text] [Related]
11. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration.
Fry AC; Singh DK; Chandna SM; Farrington K
Blood Purif; 2007; 25(3):295-302. PubMed ID: 17622712
[TBL] [Abstract][Full Text] [Related]
12. Online high-efficiency haemodiafiltration achieves higher serum free light chain removal than high-flux haemodialysis in multiple myeloma patients: preliminary quantitative study.
Granger Vallée A; Chenine L; Leray-Moragues H; Patrier L; Cognot C; Cartron G; Cristol JP; Canaud B
Nephrol Dial Transplant; 2011 Nov; 26(11):3627-33. PubMed ID: 21508098
[TBL] [Abstract][Full Text] [Related]
13. Haemodiafiltration at Higher Volumes and Patient Survival.
Locatelli F; Del Vecchio L; La Milia V
Contrib Nephrol; 2017; 189():1-8. PubMed ID: 27951544
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Single-Blind, Crossover Trial of Recovery Time in High-Flux Hemodialysis and Hemodiafiltration.
Smith JR; Zimmer N; Bell E; Francq BG; McConnachie A; Mactier R
Am J Kidney Dis; 2017 Jun; 69(6):762-770. PubMed ID: 28024931
[TBL] [Abstract][Full Text] [Related]
15. Current Evidence in Haemodiafiltration.
Locatelli F; Violo L; Longhi S; Del Vecchio L
Blood Purif; 2015; 40 Suppl 1():24-9. PubMed ID: 26344510
[TBL] [Abstract][Full Text] [Related]
16. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study.
Wizemann V; Lotz C; Techert F; Uthoff S
Nephrol Dial Transplant; 2000; 15 Suppl 1():43-8. PubMed ID: 10737166
[TBL] [Abstract][Full Text] [Related]
17. Online-haemodiafiltration vs. conventional haemodialysis: a cross-over study.
Jean G; Hurot JM; Deleaval P; Mayor B; Lorriaux C
BMC Nephrol; 2015 May; 16():70. PubMed ID: 25956949
[TBL] [Abstract][Full Text] [Related]
18. Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study.
Bammens B; Evenepoel P; Verbeke K; Vanrenterghem Y
Am J Kidney Dis; 2004 Aug; 44(2):278-85. PubMed ID: 15264186
[TBL] [Abstract][Full Text] [Related]
19. Mortality risk in patients on hemodiafiltration versus hemodialysis: a 'real-world' comparison from the DOPPS.
Locatelli F; Karaboyas A; Pisoni RL; Robinson BM; Fort J; Vanholder R; Rayner HC; Kleophas W; Jacobson SH; Combe C; Port FK; Tentori F
Nephrol Dial Transplant; 2018 Apr; 33(4):683-689. PubMed ID: 29040687
[TBL] [Abstract][Full Text] [Related]
20. Osteocalcin and myoglobin removal in on-line hemodiafiltration versus low- and high-flux hemodialysis.
Maduell F; Navarro V; Cruz MC; Torregrosa E; Garcia D; Simon V; Ferrero JA
Am J Kidney Dis; 2002 Sep; 40(3):582-9. PubMed ID: 12200811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
